Pairwise
PrivateLast Round
Series C
Sep 17, 2024
Total Funding Raised
$155M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pairwise is an agricultural technology company that uses CRISPR gene-editing technology to develop new varieties of fruits and vegetables.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, D2C Brands
Business Model
B2B
Customer Profile
Data as a Service, Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pairwise Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Pairwise Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 17, 2024 | ||||
| Series B | Feb 3, 2021 | ||||
| Series A | Mar 20, 2018 |
Pairwise Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series C, Series A, Series B |
| Temasek | Series B |
| Corteva Catalyst | Series C |
| Aliment Capital | Series C, Series B |
| Leaps by Bayer | Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Integrating precision-editing technology with AI-based trait discovery.
- Apr 10, 2026
Developing the world's first pitless cherry.
Pairwise Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pairwise's valuation, stock price, and market status.